Sage Journals: Discover world-class research

Abstract

Background:

Obesity plays a major role in the development of insulin resistance (IR) and diabetes (T2DM). Increased adipose tissue (AT) is particularly of interest because it activates a chronic inflammatory response in adipocytes and other tissues. AT plays key endocrine and metabolic functions, acting in the regulation of insulin sensitivity and energy homeostasis. Additionally, it can be easily collected during bariatric surgery. The purpose of this pilot study was to explore the potential differences in AT metabolism, through comparing the untargeted metabolomic profiles of diabetic and non-diabetic obese patients undergoing bariatric surgery.

Methods:

For this exploratory study, samples were collected from 17 subjects. Subcutaneous AT (SAT) samples from obese-diabetic (n = 8) and Obese-non-Diabetic (n = 9) subjects were obtained from the Human Metabolic Tissue Bank. Untargeted metabolomic profiling was performed by Metabolon® Inc. Statistical analysis was performed using the MetaboAnalyst 4.0 platform.

Results:

Among the 421 metabolites identified and analyzed there were no significant differences between the Obese-Diabetics and the Obese-non-Diabetics. Small changes were observed by fold change analysis mainly in lipid (n = 12; e.g. NEFAs) and amino acid (n = 8; e.g. BCAAs) metabolic pathways. Dysregulation of these metabolites has been associated with IR and other T2DM-related pathophysiological processes.

Conclusion:

Obesity may influence SAT metabolism masking T2DM-dependent dysregulation. Better understanding the metabolic differences within SAT in diabetic populations may help identify potential biomarkers for diagnosis and monitoring of T2DM in patients undergoing bariatric surgery.

Keywords

obesity diabetes (T2DM)subcutaneous adipose tissue (SAT)untargeted metabolomics insulin resistance (IR),bariatric surgery

Get full access to this article

View all access options for this article.

References

Abraham

T. M.

Pedley

Massaro

J. M.

Hoffmann

Fox

C. S.

(2015). Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation, 132(17), 1639–1647. https://doi.org/10.1161/circulationaha.114.015000

Baron

A. D.

(2002). Insulin resistance and vascular function. Journal of Diabetes and its Complications, 16(1), 92–102. https://doi.org/10.1016/S1056-8727(01)00209-4

Buchwald

Estok

Fahrbach

Banel

Jensen

M. D.

Pories

W. J.

Bantle

J. P.

Sledge

(2009). Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. The American Journal of Medicine, 122(3), 248–256.e245. https://doi.org/10.1016/j.amjmed.2008.09.041

Burhans

M. S.

Hagman

D. K.

Kuzma

J. N.

Schmidt

K. A.

Kratz

(2018). Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus. Comprehensive Physiology, 9(1), 1–58. https://doi.org/10.1002/cphy.c170040

Catalan

Gomez-Ambrosi

Rodriguez

Ramirez

Valenti

Moncada

Landecho

M. F.

Silva

Salvador

Fruhbeck

(2016). Increased interleukin-32 levels in obesity promote adipose tissue inflammation and extracellular matrix remodeling: Effect of weight loss. Diabetes, 65(12), 3636–3648. https://doi.org/10.2337/db16-0287

Chong

Wishart

D. S.

Xia

(2019). Using Metabo analyst 4.0 for comprehensive and integrative metabolomics data analysis. Current Protocols in Bioinformatics, 68(1), e86. https://doi.org/10.1002/cpbi.86

Cummins

T. D.

Holden

C. R.

Sansbury

B. E.

Gibb

A. A.

Shah

Zafar

Tang

Hellmann

Rai

S. N.

Spite

Bhatnagar

Hill

B. G.

(2014). Metabolic remodeling of white adipose tissue in obesity. American Journal of Physiology-Endocrinology and Metabolism, 307(3), E262–277. https://doi.org/10.1152/ajpendo.00271.2013

Draper

C. F.

Duisters

Weger

Chakrabarti

Harms

A. C.

Brennan

Hankemeier

Goulet

Konz

Martin

F. P.

Moco

van der Greef

(2018). Menstrual cycle rhythmicity: Metabolic patterns in healthy women. Scientific Reports, 8(1), 14568–14568. https://doi.org/10.1038/s41598-018-32647-0

Engin

(2017a). The definition and prevalence of obesity and metabolic syndrome. Advances in Experimental Medicine and Biology, 960, 1–17. https://doi.org/10.1007/978-3-319-48382-5_1

10.

Engin

(2017b). Eat and death: Chronic over-eating. Advances in Experimental Medicine and Biology, 960, 53–80. https://doi.org/10.1007/978-3-319-48382-5_3

11.

Engin

(2017c). The pathogenesis of obesity-associated adipose tissue inflammation. Advances in Experimental Medicine and Biology, 960, 221–245. https://doi.org/10.1007/978-3-319-48382-5_9

12.

Ferrannini

(2014). The target of metformin in type 2 diabetes. New England Journal of Medicine, 371(16), 1547–1548. https://doi.org/10.1056/NEJMcibr1409796

13.

Filla

L. A.

Edwards

J. L.

(2016). Metabolomics in diabetic complications. Molecular Omics, 12(4), 1090–1105. https://doi.org/10.1039/c6mb00014b

14.

Finkelstein

E. A.

Khavjou

O. A.

Thompson

Trogdon

J. G.

Pan

Sherry

Dietz

(2012). Obesity and severe obesity forecasts through 2030. American Journal of Preventive Medicine, 42(6), 563–570. https://doi.org/10.1016/j.amepre.2011.10.026

15.

Goodpaster

B. H.

Sparks

L. M.

(2017). Metabolic flexibility in health and disease. Cell Metabolism, 25(5), 1027–1036. https://doi.org/10.1016/j.cmet.2017.04.015

16.

Greenberg

A. S.

Obin

M. S.

(2006). Obesity and the role of adipose tissue in inflammation and metabolism. The American Journal of Clinical Nutrition, 83(2), 461S–465S. https://doi.org/10.1093/ajcn/83.2.461S

17.

Guasch-Ferré

Hruby

Toledo

Clish

C. B.

Martínez-González

M. A.

Salas-Salvadó

F. B.

(2016). Metabolomics in prediabetes and diabetes: A systematic review and meta-analysis. Diabetes Care, 39(5), 833–846. https://doi.org/10.2337/dc15-2251

18.

Guillet

Masgrau

Walrand

Boirie

(2012). Impaired protein metabolism: Interlinks between obesity, insulin resistance and inflammation. Obesity Reviews, 13 (Suppl 2), 51–57. https://doi.org/10.1111/j.1467-789X.2012.01037.x

19.

Han

C. Y.

(2016). Roles of reactive oxygen species on insulin resistance in adipose tissue. Diabetes & Metabolism Journal, 40(4), 272–279. https://doi.org/10.4093/dmj.2016.40.4.272

20.

Hanzu

F. A.

Vinaixa

Papageorgiou

Párrizas

Correig

Delgado

Carmona

Samino

Vidal

Gomis

(2014). Obesity rather than regional fat depots marks the metabolomic pattern of adipose tissue: An untargeted metabolomic approach. Obesity, 22(3), 698–704. https://doi.org/10.1002/oby.20541

21.

Holland

W. L.

Summers

S. A.

(2008). Sphingolipids, insulin resistance, and metabolic disease: New insights from in vivo manipulation of sphingolipid metabolism. Endocrine Reviews, 29(4), 381–402. https://doi.org/10.1210/er.2007-0025

22.

Karpe

Dickmann

J. R.

Frayn

K. N.

(2011). Fatty acids, obesity, and insulin resistance: Time for a reevaluation. Diabetes, 60(10), 2441–2449. https://doi.org/10.2337/db11-0425

23.

Kashyap

S. R.

Gatmaitan

Brethauer

Schauer

(2010). Bariatric surgery for type 2 diabetes: Weighing the impact for obese patients. Cleveland Clinic Journal of Medicine, 77(7), 468–476. https://doi.org/10.3949/ccjm.77a.09135

24.

Kim

W. J.

Park

C. Y.

(2013). 1,5-Anhydroglucitol in diabetes mellitus. Endocrine, 43(1), 33–40. https://doi.org/10.1007/s12020-012-9760-6

25.

Koster

J. C.

Permutt

M. A.

Nichols

C. G.

(2005). Diabetes and insulin secretion: The ATP-sensitive K+ channel (K ATP) connection. Diabetes, 54(11), 3065–3072. https://doi.org/10.2337/diabetes.54.11.3065

26.

Kucera

Spacil

Friedecky

Novak

Pekar

Bienertova-Vasku

(2018). Human white adipose tissue metabolome: Current perspective. Obesity (Silver Spring), 26(12), 1870–1878. https://doi.org/10.1002/oby.22336

27.

Kusminski

C. M.

Bickel

P. E.

Scherer

P. E.

(2016). Targeting adipose tissue in the treatment of obesity-associated diabetes. Nature Reviews Drug Discovery, 15(9), 639–660. https://doi.org/10.1038/nrd.2016.75

28.

Longo

Zatterale

Naderi

Parrillo

Formisano

Raciti

G. A.

Beguinot

Miele

(2019). Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. International Journal of Molecular Sciences, 20(9). https://doi.org/10.3390/ijms20092358

29.

Martins

B. R.

Gomes

L. C.

Boritza

K. C.

Anghebem-Oliveira

M. I.

Souza

E. M.

Franca

S. N.

Picheth

Rego

F. G. M.

(2019). Serum 1,5-anhydroglucitol concentration as a biomarker for type 1 diabetes in adults and children. Clinical Laboratory, 65(9). https://doi.org/10.7754/Clin.Lab.2019.190141

30.

McGill

J. B.

Cole

T. G.

Nowatzke

Houghton

Ammirati

E. B.

Gautille

Sarno

M. J.

(2004). Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: A U.S. trial of the GlycoMark assay. Diabetes Care, 27(8), 1859–1865. https://doi.org/10.2337/diacare.27.8.1859

31.

McLaughlin

Craig

Liu

L. F.

Perelman

Allister

Spielman

Cushman

S. W.

(2016). Adipose cell size and regional fat deposition as predictors of metabolic response to overfeeding in insulin-resistant and insulin-sensitive humans. Diabetes, 65(5), 1245–1254. https://doi.org/10.2337/db15-1213

32.

Mingrone

Cummings

D. E.

(2016). Changes of insulin sensitivity and secretion after bariatric/metabolic surgery. Surgery for Obesity and Related Diseases, 12(6), 1199–1205. https://doi.org/10.1016/j.soard.2016.05.013

33.

Nathan

D. M.

(2002). Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. The New England Journal of Medicine, 347(17), 1342–1349. https://doi.org/10.1056/NEJMcp021106

34.

Neeland

I. J.

Turer

A. T.

Ayers

C. R.

Powell-Wiley

T. M.

Vega

G. L.

Farzaneh-Far

Grundy

S. M.

Khera

McGuire

D. K.

de Lemos

J. A.

(2012). Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA, 308(11), 1150–1159. https://doi.org/10.1001/2012.jama.11132

35.

Pallares-Mendez

Aguilar-Salinas

C. A.

Cruz-Bautista

Del Bosque-Plata

(2016). Metabolomics in diabetes, a review. Annals of Medicine, 48(1–2), 89–102. https://doi.org/10.3109/07853890.2015.1137630

36.

Paniagua

J. A.

(2016). Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome. World Journal of Diabetes, 7(19), 483–514. https://doi.org/10.4239/wjd.v7.i19.483

37.

Perin

Pittet

J. C.

Schnebert

Perrier

Tranquart

Beau

(2000). Ultrasonic assessment of variations in thickness of subcutaneous fat during the normal menstrual cycle. European Journal of Ultrasound, 11(1), 7–14. https://doi.org/10.1016/S0929-8266(99)00070-1

38.

Riekeberg

Powers

(2017). New frontiers in metabolomics: From measurement to insight. F1000Res, 6, 1148. https://doi.org/10.12688/f1000research.11495.1

39.

Saltiel

A. R.

Olefsky

J. M.

(2017). Inflammatory mechanisms linking obesity and metabolic disease. The Journal of Clinical Investigation, 127(1), 1–4. https://doi.org/10.1172/jci92035

40.

Sarosiek

Pappan

K. L.

Gandhi

A. V.

Saxena

Kang

C. Y.

McMahon

Chipitsyna

G. I.

Tichansky

D. S.

Arafat

H. A.

(2016). Conserved metabolic changes in nondiabetic and type 2 diabetic bariatric surgery patients: Global metabolomic pilot study. Journal of Diabetes Research, 2016, 3467403-3467403. https://doi.org/10.1155/2016/3467403

41.

Schmid

A. I.

Szendroedi

Chmelik

Krssak

Moser

Roden

(2011). Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care, 34(2), 448–453. https://doi.org/10.2337/dc10-1076

42.

Sobczak

A. I. S.

Blindauer

C. A.

Stewart

A. J.

(2019). Changes in plasma free fatty acids associated with type-2 diabetes. Nutrients, 11(9), 2022. https://doi.org/10.3390/nu11092022

43.

Spalding

K. L.

Arner

Westermark

P. O.

Bernard

Buchholz

B. A.

Bergmann

Blomqvist

Hoffstedt

Näslund

Britton

Concha

Hassan

Rydén

Frisén

Arner

(2008). Dynamics of fat cell turnover in humans. Nature, 453(7196), 783–787. https://doi.org/10.1038/nature06902

44.

Sparks

D. L.

Doelle

Chatterjee

(2014). Circulating nucleotide levels in health and disease Extracellular nucleotides and disease. Receptors and Clinical Investigation. https://www.smartscitech.com/index.php/rci/article/view/311

45.

Storey

J. D.

Tibshirani

(2003). Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences, 100(16), 9440–9445. https://doi.org/10.1073/pnas.1530509100

46.

Sun

Kusminski

C. M.

Scherer

P. E.

(2011). Adipose tissue remodeling and obesity. The Journal of Clinical Investigation, 121(6), 2094–2101. https://doi.org/10.1172/JCI45887

47.

Valencak

T. G.

Osterrieder

Schulz

T. J.

(2017). Sex matters: The effects of biological sex on adipose tissue biology and energy metabolism. Redox Biology, 12, 806–813. https://doi.org/10.1016/j.redox.2017.04.012

48.

Vangipurapu

Stancakova

Smith

Kuusisto

Laakso

(2019). Nine amino acids are associated with decreased insulin secretion and elevated glucose levels in a 7.4-year follow-up study of 5,181 Finnish men. Diabetes, 68(6), 1353–1358. https://doi.org/10.2337/db18-1076

49.

Villarreal-Calderón

J. R.

Cuéllar

R. X.

Ramos-González

M. R.

Rubio-Infante

Castillo

E. C.

Elizondo-Montemayor

García-Rivas

(2019). Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery. Oxidative Medicine and Cellular Longevity, 2019, 3940739. https://doi.org/10.1155/2019/3940739

50.

Wallace

Hashim

Y. Z. H.-Y.

Wingfield

Culliton

McAuliffe

Gibney

M. J.

Brennan

(2010). Effects of menstrual cycle phase on metabolomic profiles in premenopausal women. Human Reproduction, 25(4), 949–956. https://doi.org/10.1093/humrep/deq011

51.

Wang

Q. A.

Tao

Gupta

R. K.

Scherer

P. E.

(2013). Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nature Medicine, 19(10), 1338–1344. https://doi.org/10.1038/nm.3324

52.

World Health Organization. (2018, February 16). Obesity and overweight. https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight

53.

(2009). Amino acids: Metabolism, functions, and nutrition. Amino Acids, 37(1), 1–17. https://doi.org/10.1007/s00726-009-0269-0

54.

Qiao

Shi

Wang

(2018). Metabolomics window into diabetic complications. Journal of Diabetes Investigation, 9(2), 244–255. https://doi.org/10.1111/jdi.12723

55.

Zhang

Zhou

(2015). Associations of different adipose tissue depots with insulin resistance: A systematic review and meta-analysis of observational studies. Scientific Reports, 5, 18495. https://doi.org/10.1038/srep18495

56.

Zhou

Shao

C.-Y.

Shu

Dong

Liu

Chen

Wynn

R. M.

Wang

Gui

W. J.

Lusis

A. J.

Wang

Ning

Yang

Chuang

D. T.

Wang

Sun

(2019). Targeting BCAA catabolism to treat obesity-associated insulin resistance. Diabetes, 68(9), 1730–1746. https://doi.org/10.2337/db18-0927

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.13 MB

Untargeted Metabolomic Approach Shows No Differences in Subcutaneous Adipose Tissue of Diabetic and Non-Diabetic Subjects Undergoing Bariatric Surgery: An Exploratory Study

Abstract

Background:

Methods:

Results:

Conclusion:

Keywords

Get full access to this article

References

Supplementary Material